HG204
HG20401
Unknown gene_therapy active
Quick answer
HG204 for MECP2 Duplication Syndrome is a Unknown program (gene_therapy) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- MECP2 Duplication Syndrome
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active